Gut microbial signatures and immunotherapy outcomes in NSCLC and melanoma: a systematic review and meta-analysis

Abstract Background The composition of the gut microbiome has been linked to clinical responses to immune checkpoint inhibitors (ICIs), but its prognostic association with outcomes in non-small cell lung cancer (NSCLC) and melanoma remains incompletely defined. We performed a systematic review and m...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mohammed Elmujtba Adam Essa, Hamid Noori, James Butler, Abdelkareem A. Ahmed
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-02-01
Col·lecció:	BMC Cancer
Matèries:	gut microbiome immune checkpoint inhibitors NSCLC melanoma Akkermansia Faecalibacterium
Accés en línia:	https://doi.org/10.1186/s12885-026-15763-3
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!